Signal Advisors Wealth’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
NI
WN
SRS
FFO
Signal Advisors Wealth's HCAT Position: Q3 2026 in Review
Signal Advisors Wealth reduced its Health Catalyst (HCAT) stake by 3% in Q3 2026, selling an estimated $1.03K and leaving 17,538 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #699.
Signal Advisors Wealth first reported a position in HCAT in Q2 2025 and has held it in 6 quarters since. The position peaked at $645K in Q2 2025. 5 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- Signal Advisors Wealth held 17,538 shares of Health Catalyst worth $30.3K as of Q3 2026.
- Signal Advisors Wealth sold 542 Health Catalyst shares in Q3 2026, an estimated $1.03K.
- Health Catalyst made up ﹤0.01% of Signal Advisors Wealth's portfolio in Q3 2026, its #699 holding.
- Signal Advisors Wealth first reported a position in Health Catalyst in Q2 2025 and has held it in 6 quarters since.
- Signal Advisors Wealth's Health Catalyst position peaked at $645K in Q2 2025.
- 5 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on Signal Advisors Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.